CompletedNot Applicable

Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB

China211 participantsStarted 2013-06

Plain-language summary

The aim of the present study was to assess whether it was necessary to conduct magnifying endoscopy with narrow band imaging (ME-NBI) targeted biopsy compared with endoscopic forceps biopsy (EFB) from white light endoscopy in diagnosing early gastric cancer (EGC). Meanwhile, the investigators proposed the most cost-effective way to diagnose EGC.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * consecutive patients with gastric lesions detected by white light endoscopy and suspected of EGC Exclusion Criteria: * they had advanced gastric cancer * lesions were histopathologically confirmed to be submucosal tumors * they had a history of gastrectomy * tissue biopsy wasn't obtained or more than 2 biopsies were performed on suspected gastric lesions during last white light endoscopy * they couldn't tolerate another endoscopic examination

What they're measuring

Accuracy in distinguishing high-grade neoplasia (HGN) from non-HGN

Timeframe: 30 months

Sensitivity in distinguishing HGN from non-HGN

Timeframe: 30 months

Specificity in distinguishing HGN from non-HGN

Timeframe: 30 months

Trial details

NCT IDNCT02738294

SponsorShanghai Jiao Tong University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Early Gastric Cancer trials